↵
Product Introduction
Name:Adipotide
Product Benefits:Improves weight management and promotes fat loss
CAS:859216-15-2
Capacity:2mg/vial
Product Form:White or off-white powder(Peptides)
Shelf Life:2-3Years(The product packaging date shall prevail)
What is Adipotide?
**Adipotide** is an experimental peptide drug with potential applications in weight loss and fat reduction. It was developed by American biopharmaceutical company **Tarascon** and has shown significant fat reduction effects in preclinical studies. Adipotide mainly promotes the degradation of fat by acting on the vascular system of adipose tissue, so it is considered to have certain prospects in weight management and treatment of obesity.
### **Physical and Chemical Properties**
Adipotide is a synthetic peptide, usually composed of a series of amino acids, with high lipophilicity and strong targeting effect. Its chemical structure includes a specific amino acid sequence that binds to specific receptors in fat tissue. The molecular structure of this peptide allows it to act precisely on the blood vessels of fat tissue, causing atrophy and reduction of fat cells.
### **Mechanism of action**
Adipotide's mechanism of action is relatively unique in that it works in the following ways:
1. **Targeting fat blood vessels**: Adipotide induces the degeneration of fat blood vessels by binding to specific receptors on vascular endothelial cells in adipose tissue (such as vascular endothelial cell growth factor receptors in adipose tissue).
2. **Destroy the blood supply to fat cells**: By destroying the blood vessels of fat tissue, Adipotide can effectively cut off the nutrient supply to fat cells, leading to the degradation of fat tissue.
3. **Induce fat cell death**: This type of effect causes fat cells to gradually become smaller and die, thereby effectively reducing fat reserves in the body.
### **Dosage and Use**
Adipotide has been used primarily in preclinical animal experiments and has not yet been widely used as a human treatment. However, some early research results show significant fat-loss effects in rats and monkeys. The dose is usually adjusted based on the animal model being studied, and is usually administered by injection.
- **Common dosage**: In experiments, the dosage of Adipotide is generally between 2-5 mg/kg. Dosage and dosing periods vary depending on the purpose of the study (e.g., long-term fat loss or short-term experimentation).
- **Dosing Period**: Adipotide is usually administered over a period of several weeks, depending on the study objectives. Common dosing cycles are 2-6 weeks. Studies have shown that Adipotide can significantly reduce body fat when given repeatedly over a period of time.
### **Half-life and Pharmacokinetics**
Adipotide has a relatively short half-life, typically ranging from hours to days in the body, depending on the mode of administration and animal model. Because Adipotide is a peptide molecule, its metabolic pathway is similar to other small molecule drugs and is degraded through the action of enzymes in the body.
- **Half-life**: For Adipotide, animal studies show that its half-life in the body is typically about **2 to 4 hours**. This shorter half-life suggests that it requires regular dosing to maintain effective concentrations.
- **Metabolic Pathways**: Adipotide is metabolized in the body by organs such as the liver and kidneys, and is ultimately excreted in the urine.
### **Cycle and function**
- **Fat Loss Results**: The effects of Adipotide usually take several weeks to appear. Rat studies show that Adipotide can significantly reduce fat mass in 2-3 weeks, especially in the abdominal and visceral fat areas. Adipotide is effective in reducing obesity by reducing the blood supply to fat tissue.
- **Duration of Fat Loss**: Although Adipotide has a significant effect on fat loss, this effect may gradually return after discontinuation of administration, suggesting that its effect is temporary. Therefore, regular use or in combination with other treatments is often required to achieve sustained fat loss.
### **Preclinical Research and Application**
Currently, Adipotide is primarily in the **preclinical research** stage and has not yet been widely used in humans. Animal experiments (including rats and monkeys) have shown that Adipotide can effectively reduce body fat and improve metabolic markers, such as reducing abdominal fat and visceral fat, without significant side effects.
- **Obesity Treatment**: In animal models of obesity, Adipotide has shown significant fat reduction effects. The drug achieves weight loss by destroying blood vessels in fat tissue and reducing the number of fat cells.
- **Metabolic Improvements**: In addition to fat loss, Adipotide may help improve insulin sensitivity and reduce blood sugar levels, which makes it potentially useful in the treatment of metabolic syndrome, diabetes, and more.
### **Side Effects and Risks**
Although Adipotide shows potential for fat loss, there are some potential side effects and risks:
1. **Vascular Problems**: Since Adipotide's mechanism of action is by destroying blood vessels in adipose tissue, it may cause local blood flow disorders or other vascular injuries.
2. **Excessive atrophy of fat cells**: Excessive reduction of fat tissue may lead to an imbalance in fat metabolism, causing negative reactions in other tissues or organs in the body.
3. **Potential effects on the cardiovascular system**: When destroying fat blood vessels, cardiovascular functions closely related to adipose tissue may be affected.
### **Summarize**
Adipotide is a potential fat-loss drug that works by targeting the vasculature of adipose tissue, resulting in the reduction of fat cells. Although it has shown significant fat-reducing effects in animal studies, it is still in the preclinical stage and has not yet been approved for human treatment. Future clinical trials and research may further reveal its application potential in areas such as obesity and metabolic syndrome.
How does Adipotide work
Adipotide (also known as F7, chemical name is adipotoxin) is an experimental fat-reducing peptide (peptide), which is mainly studied for weight loss and improving body fat distribution. It acts on fat cells through a specific molecular mechanism to promote fat loss. The following is a detailed introduction to its applicable population, working principle, and usage and dosage.
### 1. **Applicable population**
Adipotide is currently in the clinical research stage and has not yet been formally approved for general clinical use. It is mainly studied for the following groups of people:
- **Obese people**: It is suitable for those who have tried conventional weight loss methods (such as diet control, exercise, etc.) and still have difficulty in reaching their ideal weight or body fat level.
- **Local fat people**: Some studies have shown that Adipotide has a significant effect on reducing abdominal or visceral fat (especially visceral fat), so it may be beneficial for people with obese body shape and uneven fat distribution.
- **Weight management population**: For those who want to improve their health by controlling fat levels, Adipotide may become an auxiliary means.
### 2. **How it works**
Adipotide works by targeting and promoting apoptosis (programmed cell death) of fat cells to reduce fat. This is done by binding to specific receptors on the surface of fat cells, inducing the rupture and death of fat cells.
- **Targeting fat cells**: Adipotide acts directly on fat cells by binding to a specific protein called **ATP-dependent proteasome-associated receptor (FAS receptor)**. This receptor is abundant on the surface of fat cells, and Adipotide enters fat cells and induces fat cell death by binding to these receptors.
- **Fat consumption**: As fat cells die, fatty acids stored in fat cells are released into the bloodstream for the body to use for energy consumption. This process promotes fat burning and body fat reduction.
- **Increases metabolism**: Adipotide is believed to reduce fat mass not only by directly killing fat cells, but also by accelerating metabolism, which may enhance the body's ability to burn fat.
### 3. **Dosage and administration**
The dosage and method of using Adipotide vary depending on different clinical studies. It is usually administered by injection, but the specific usage and dosage have not been standardized. Here is some reference information based on some early studies:
- **Dosage**: Adipotide is generally administered by subcutaneous injection or intramuscular injection.
- **Dosage**: In animal experiments, the dosage of Adipotide is usually in the range of a few micrograms to tens of micrograms per day. However, the specific clinical dosage has not been fully determined and needs to be adjusted individually based on research results and doctor's advice.
- **Course**: Adipotide is usually treated as a short-term course of treatment, which may be 4 to 8 weeks. During this period, researchers will monitor its effect on fat loss and possible side effects.
### 4. **Side effects and risks**
Because Adipotide is still in the experimental stage, long-term data on its side effects are very limited. Some known potential side effects include:
- **Dehydration and electrolyte imbalance**: Because it acts on fat cells and metabolic mechanisms, it may cause changes in body water and electrolytes.
- **Immune response**: As an exogenous peptide, Adipotide may trigger a response from the immune system, especially for long-term or high-dose use.
- **Fast fat loss**: Rapid fat loss may cause some negative effects, such as sagging skin, metabolic disorders or malnutrition.
### 5. **Conclusion**
Adipotide, as an experimental peptide for weight loss and fat reduction, has not yet been widely approved for use, and its effectiveness and safety require more research to verify. Its potential lies in inducing apoptosis of adipocytes by targeting them, thereby achieving rapid fat loss. However, since it has not yet been widely clinically validated, it needs to be used with caution and under appropriate medical guidance.
Adipotide related advantages
**Adipotide** (also known as **F13A**) is a peptide molecule that has attracted attention primarily for its potential in fat metabolism and weight management. It was first developed by US researchers and tested in animal models. Adipotide promotes lipolysis and reduces body fat storage primarily by targeting specific receptors in adipose tissue. Here are the main benefits and possible health effects of Adipotide:
### 1. **Promote fat loss**
Adipotide is best known for promoting body fat loss. Research shows that by targeting and acting on specific receptors in fat tissue, it can stimulate fat cell apoptosis (the self-destruction of fat cells), thereby reducing fat storage. This mechanism of action of Adipotide helps reduce excess fat in the body, especially abdominal fat, and has a significant fat reduction effect.
### 2. **Improve weight management**
Adipotide can significantly reduce body fat and help people control their weight more effectively. It may help reduce health problems caused by obesity by promoting the breakdown of fats. Preclinical studies have shown that animals treated with Adipotide experienced significant reductions in body weight, particularly abdominal and visceral fat.
### 3. **Enhance fat metabolism**
Adipotide can enhance the lipolysis process by activating pathways related to fat metabolism. This effect is not limited to reducing fat storage, but may also increase energy consumption by improving fat metabolism, making weight loss more efficient.
### 4. **Improve insulin sensitivity**
Research shows that Adipotide may have a positive effect on insulin sensitivity. Insulin resistance is one of the key factors in obesity, type 2 diabetes and metabolic syndrome. By reducing body fat and improving fat metabolism, Adipotide has the potential to help reduce insulin resistance and improve blood sugar control, thereby combating diabetes and its related metabolic diseases.
### 5. **Protect cardiovascular health**
Excess fat, especially visceral fat, is often associated with a higher risk of cardiovascular disease. Adipotide may indirectly improve cardiovascular health by reducing fat stores, especially visceral fat. Reducing body fat can help lower blood pressure, improve cholesterol levels, and reduce the risk of cardiovascular problems such as arteriosclerosis.
### 6. **Inhibit adipocyte production**
In addition to promoting the apoptosis of fat cells, Adipotide may also help maintain lower body fat levels long-term by inhibiting the production of new fat cells. By reducing the production of new fat cells, it helps prevent fat from reaccumulating in the body.
### 7. **Treatment of Obesity and Metabolic Syndrome**
Due to its significant fat-reducing effects, Adipotide may become a potential treatment for obesity and related metabolic diseases such as metabolic syndrome, diabetes, and hyperlipidemia. By reducing excess fat and improving fat metabolism, it can help reduce the health burden of obesity.
### 8. **Potential anti-aging effects**
Although Adipotide has been primarily studied as a fat-reducing agent, excess fat is considered a negative factor in the aging process. Reducing excess fat, especially visceral fat, may indirectly improve the aging process and reduce the incidence of chronic diseases caused by obesity (such as cardiovascular disease, diabetes, etc.). Therefore, Adipotide may also have potential in the anti-aging field.
### 9. **Enhance athletic performance and endurance**
Reducing body fat may result in a higher muscle ratio and lower body weight, thereby improving athletic performance and endurance. For athletes and fitness enthusiasts, Adipotide may help optimize body composition and improve athletic performance, especially in sports that require endurance and power.
### 10. **Potential anti-tumor effect**
Some preliminary studies suggest that Adipotide may have inhibitory effects on certain types of tumor cells, specifically affecting tumor growth by reducing the supply of fat around tumors. Although research in this area is still in its early stages, this potential anti-tumor effect provides broader prospects for the application of Adipotide.
### 11. **Improve skin health**
Reducing body fat, especially visceral fat, has indirect benefits for skin health. Because fat loss may improve blood circulation and hormone levels, Adipotide may improve skin elasticity and radiance through these mechanisms and reduce skin problems associated with aging.
---
### **Adipotide Risks and Side Effects**
Although Adipotide has shown many potential benefits in animal models, its long-term effects and safety in humans remain unproven. Its side effects may include:
- **Excessive fat loss**: Excessive fat loss may lead to unstable hormone levels in the body and affect physiological balance.
- **Muscle Loss**: While losing fat, without adequate exercise and nutritional support, muscle loss may occur.
- **Immune System Reaction**: Adipotide may trigger an immune system reaction, leading to allergic reactions or other adverse reactions.
Therefore, although Adipotide shows potential for fat loss and metabolic improvement, more clinical trials and long-term studies are needed to confirm its safety and effectiveness before it can be widely used.
### Summarize
Adipotide is a new type of peptide molecule that mainly promotes fat cell apoptosis and improves fat metabolism to achieve many potential benefits such as fat loss, improvement of insulin sensitivity, and improvement of cardiovascular health. Although research suggests it may have great potential in treating obesity, metabolic syndrome and related conditions, more research is needed to verify its safety and effectiveness in humans.
Contact Details(WhatsApp Telegram ) And Payment Methods
WhatsApp/Telegram:+852 6749 2648
Gmail:lucasraws207@gmail.com
Skype：live:.cid.8f21dc7fc6621ba7
FAQ
Q: Is Adipotide approved for clinical use?
A: Currently, Adipotide has not received drug approval in any country. It is still in the preclinical and early clinical trial stages. Much of the research has focused on animal models, such as mice and monkeys, where researchers are evaluating its effectiveness and safety in reducing fat and treating obesity.
Q: What are the potential benefits of Adipotide?
A: Potential benefits of Adipotide include:
- **Significant Fat Loss**: In animal studies, Adipotide significantly reduced body fat, especially in the abdominal fat area.
- **Targeting adipocytes**: Unlike traditional weight loss drugs, Adipotide acts directly on adipocytes and does not rely on the regulation of systemic metabolism.
- **Potential treatment for obesity-related diseases**: Because it improves metabolism by reducing fat, Adipotide has the potential to be used to treat obesity-related diseases such as diabetes, high blood pressure, and high cholesterol.
Q: How is Adipotide different from other weight loss medications?
A: - **Targeted Action**: Most traditional weight loss drugs work by modulating appetite or energy expenditure (such as through drugs that suppress appetite or drugs that increase metabolism). Adipotide reduces fat storage by directly targeting fat cells and inducing their apoptosis.
- **SIDE EFFECTS**: Many weight loss drugs have some common side effects, such as decreased appetite, anxiety, or headaches. While Adipotide focuses on the reduction of fat cells, the side effects may be related to the effects of rapid fat loss.
Q: How effective is Adipotide in animal studies?
A: In early animal studies, particularly in rats and monkeys, Adipotide showed significant fat-reducing effects. Studies have found that Adipotide is effective in reducing weight and fat in the short term without affecting food intake. Research also shows that Adipotide works primarily on abdominal fat, an area that is often associated with a higher risk of metabolic diseases such as diabetes and cardiovascular disease.
Hot Tags: peptides adipotide 2mg cas：859216-15-2, China peptides adipotide 2mg cas：859216-15-2 manufacturers, suppliers, factory, Follistatin 344 and Fst 344, PEG MGF Accelerate recovery and improve training effect, AOD9604 No effect on blood sugar and growth, TB500 Improve muscle tension, Ipamorelin CAS 170851 70 4, Hexarelin CAS 140703 51 1
